Drug Database
Back to search

Canada· CA-DIN-02454424

DESCOVY

A emtricitabine and tenofovir alafenamide product containing tenofovir alafenamide (tenofovir alafenamide hemifumarate) + emtricitabine, registered in Canada by GILEAD SCIENCES CANADA INC. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR17

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedDESCOVYATCJ05AR17REGISTER NO.CA-DIN-02454424PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tenofovir alafenamide (tenofovir alafenamide hemifumarate) + emtricitabineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine and tenofovir alafenamide is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR17 (emtricitabine and tenofovir alafenamide), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 8 of them publish a price we can compare per daily dose
Search emtricitabine and tenofovir alafenamide products by name

Emtricitabine and tenofovir alafenamide · ATC J05AR17

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE) + EMTRICITABINE
Manufacturer
GILEAD SCIENCES CANADA INC
Country
Canada (CA)
ATC code
J05AR17
ATC class
Emtricitabine and tenofovir alafenamide
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emtricitabine and tenofovir alafenamide in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine and tenofovir alafenamide products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Czechia · Emtricitabine/Tenofovir Alafenamide Zentiva
  • Denmark · Emtricitabin/Tenofoviralafenamid Lupin, Emtricitabine/Tenofovir Alafenamide Medical Valley
  • Spain · Emtricitabina/Tenofovir Alafenamida Dr. Reddys, Emtricitabina/Tenofovir Alafenamida Zentiva
  • Finland · Emtricitabine/Tenofovir Alafenamide Lupin
  • France · Emtricitabine/Tenofovir Alafenamide Zentiva
  • United Kingdom (Northern Ireland) · Emtricitabine/Tenofovir Alafenamide Amarox, Emtricitabine/Tenofovir Alafenamide Zentiva Pharma
  • Iceland · Descovy, Emtricitabine/Tenofovir Alafenamide Viatris
  • Italy · Emtricitabina E Tenofovir Alafenamide Zentiva
  • Liechtenstein · Descovy, Emtricitabine/Tenofovir Alafenamide Viatris
  • Netherlands · Emtricitabine/Tenofovir Alafenamide Zentiva, Emtricitabine/Tenofoviralafenamide Lupin
  • Norway · Descovy, Emtricitabine/ Tenofovir Alafenamide Lupin
  • Portugal · Emtricitabina + Tenofovir Alafenamida Zentiva
  • Sweden · Emtricitabine/ Tenofovir Alafenamide Lupin, Emtricitabine/Tenofovir Alafenamide Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f3c4d16b-a344-48e1-bb07-c04dae6bbb98
GET /v1/drugs/f3c4d16b-a344-48e1-bb07-c04dae6bbb98?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02454424",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "J05AR17",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "94100",
  "strengths": [
    "25 MG",
    "200 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE)",
    "EMTRICITABINE"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about emtricitabine and tenofovir alafenamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console